Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

XANAX 2 MG TABLET

alprazolam
$15.9501per EA
High Outlier
DEA Schedule CIV

Strength

2 mg/1

Manufacturer

Pharmacia & Upjohn Company LLC

NDC

00009009401

Classification

Brand

Dosage Form

TABLET

Route

ORAL

Last Updated

1/1/2026

Active Ingredients

ALPRAZOLAM

Approval Type

New Drug (NDA)

FDA Application

NDA018276

On Market Since

10/16/1981

Pharmacological Classes

Benzodiazepine
Benzodiazepines

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+4.9%

1Y

+4.9%

3Y

+13.7%

5Y

+27.6%

All

+232.5%

Generic Alternatives

Save up to 100%

2 alternatives • Same active ingredient

ALPRAZOLAM 2 MG TABLET
Generic
59762372203•Mylan Pharmaceuticals Inc.
$0.0458
Save 100%
XANAX 2 MG TABLET
Brand
58151045501•Viatris Specialty LLC
$15.9500

Related Drugs

Same classification

KLONOPIN 0.5 MG TABLET
Brand
61269060510•H2-Pharma LLC
$2.6797
per EA
KLONOPIN 1 MG TABLET
Brand
61269061010•H2-Pharma LLC
$3.0637
per EA
KLONOPIN 2 MG TABLET
Brand
61269062010•H2-Pharma LLC
$4.2603
per EA
HALCION 0.25 MG TABLET
Brand
00009001755•Pharmacia & Upjohn Company LLC
$5.3212
per EA
HALCION 0.25 MG TABLET
Brand
00009001758•Pharmacia & Upjohn Company LLC
$5.3212
per EA
ONFI 2.5 MG/ML SUSPENSION
Brand
67386031321•Lundbeck Pharmaceuticals LLC
$12.4722
per ML
LOREEV XR 2 MG CAPSULE
Brand
52427066330•Almatica Pharma LLC
$14.2359
per EA
LOREEV XR 1.5 MG CAPSULE
Brand
52427066130•Almatica Pharma LLC
$14.2367
per EA
LOREEV XR 3 MG CAPSULE
Brand
52427066730•Almatica Pharma LLC
$14.2402
per EA
LOREEV XR 1 MG CAPSULE
Brand
52427065830•Almatica Pharma LLC
$14.2455
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy